Tuesday, April 15, 2014 5:07:28 PM
I'm still trying to figure out Hargove's end game here. I go back and forth with him. We all know he's being paid in stock so continued progress is imperative to him. My problem is he hasn't been around nearly as long as the others. It's not as emotional to him, and not his "baby". I can see him pushing for a buyout at 10 and move on.
On the other hand, if he's willing to hang in there a couple extra years his payday goes from 5-10 million (or whatever) to tens of millions. This isn't any ordinary opportunity here. I hope he is a patient man.
JMHO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM